These patient-based findings agree with our findings in HeLa cells using LEAP assays (Figure 7B, C) as well as a ruler PCR assay (Figure 8) and demonstrates that variation in TRIM28 expression levels in vivo may influence the length of de novo L1 inserts in at least three different cancer types as well as in both sexes. Here, TRIM28 is linked to cancer.